Avantor Sees Unusually High Options Volume (NYSE:AVTR)

Avantor, Inc. (NYSE:AVTRGet Rating) saw unusually large options trading on Friday. Investors acquired 20,049 call options on the stock. This is an increase of 602% compared to the typical daily volume of 2,857 call options.

Avantor Stock Up 1.4 %

Avantor stock opened at $21.62 on Friday. Avantor has a fifty-two week low of $17.91 and a fifty-two week high of $42.48. The company has a debt-to-equity ratio of 1.29, a quick ratio of 1.07 and a current ratio of 1.65. The firm has a 50 day moving average price of $21.14 and a 200 day moving average price of $26.85. The company has a market capitalization of $14.58 billion, a PE ratio of 23.00 and a beta of 1.37.

Avantor (NYSE:AVTRGet Rating) last posted its quarterly earnings results on Friday, October 28th. The company reported $0.34 EPS for the quarter, topping the consensus estimate of $0.33 by $0.01. The business had revenue of $1.86 billion during the quarter, compared to the consensus estimate of $1.85 billion. Avantor had a net margin of 8.38% and a return on equity of 24.67%. The company’s quarterly revenue was up 1.2% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.35 earnings per share. Research analysts expect that Avantor will post 1.39 earnings per share for the current year.

Hedge Funds Weigh In On Avantor

Institutional investors have recently modified their holdings of the business. Dark Forest Capital Management LP grew its stake in shares of Avantor by 165.0% during the second quarter. Dark Forest Capital Management LP now owns 1,346 shares of the company’s stock worth $42,000 after purchasing an additional 838 shares in the last quarter. Nisa Investment Advisors LLC grew its stake in shares of Avantor by 794.5% during the third quarter. Nisa Investment Advisors LLC now owns 2,120 shares of the company’s stock worth $42,000 after purchasing an additional 1,883 shares in the last quarter. Alta Advisers Ltd acquired a new position in shares of Avantor during the third quarter worth $47,000. TFC Financial Management acquired a new position in shares of Avantor during the third quarter worth $51,000. Finally, Quadrant Capital Group LLC grew its stake in shares of Avantor by 217.8% during the second quarter. Quadrant Capital Group LLC now owns 2,031 shares of the company’s stock worth $63,000 after purchasing an additional 1,392 shares in the last quarter. Institutional investors and hedge funds own 81.22% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities research analysts recently issued reports on AVTR shares. UBS Group lowered their price objective on Avantor to $33.00 in a report on Friday, November 4th. Credit Suisse Group lowered their price objective on Avantor from $32.00 to $25.00 and set a “neutral” rating on the stock in a report on Monday, October 31st. Wells Fargo & Company lowered their price objective on Avantor from $33.00 to $27.00 and set an “overweight” rating on the stock in a report on Monday, October 31st. Stifel Nicolaus lowered their price objective on Avantor from $35.00 to $28.00 in a report on Monday, September 19th. Finally, KeyCorp lowered their price objective on Avantor from $51.00 to $40.00 and set an “overweight” rating on the stock in a report on Thursday, September 15th. Three research analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $28.93.

Avantor Company Profile

(Get Rating)

Avantor, Inc provides products and services to customers in biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.

Featured Articles

Receive News & Ratings for Avantor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avantor and related companies with MarketBeat.com's FREE daily email newsletter.